Lucia Saccuzzo

Dr. Lucia Saccuzzo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
FSFederica Saia
Federica Saia
APAdriana Prato
Adriana Prato
LSLucia Saccuzzo
Lucia Saccuzzo
FMFrancesca Madia
Francesca Madia
RBRita Barone
Rita Barone
RRRenata Rizzo
Renata Rizzo
Tourette syndrome (TS) is a neurodevelopmental disturbance with heterogeneous and not completely known etiology. Clinical and molecular appraisal of affected patients is mandatory for outcome amelioration. The current study aimed to understand the molecular bases underpinning TS in a vast cohort of pediatric patients with TS. Molecular analyses included array-CGH analyses. The primary goal was to define the neurobehavioral phenotype of patients with or without pathogenic copy number variations (CNVs). Moreover, we compared the CNVs with CNVs described in the literature in neuropsychiatric disorders, including TS, to describe an effective clinical and molecular characterization of patients for prognostic purposes and for correctly taking charge. Moreover, this study showed that rare deletions and duplications focusing attention on significant genes for neurodevelopment had a statistically higher occurrence in children with tics and additional comorbidities. In our cohort, we determined an incidence of potentially causative CNVs of about 12%, in line with other literature studies. Clearly, further studies are needed to delineate the genetic background of patients with tic disorders in a superior way to elucidate the complex genetic architecture of these disorders, to describe the outcome, and to identify new possible therapeutic targets.

5 November 2025 in Genes
Verified
Journal Article
Open access
PDF file
RFRaffaele Falsaperla
Raffaele Falsaperla
ESEliana Salvo
Eliana Salvo
ASAnnamaria Sapuppo
Annamaria Sapuppo
CBChiara Barberi
Chiara Barberi
VSVincenzo Sortino
Vincenzo Sortino
MBMaria Clara Bonaglia
Maria Clara Bonaglia
Background: Pyridoxine-dependent epilepsy (PDE) is a rare disorder characterized by seizures resistant to conventional treatments but responsive to pyridoxine therapy. Typically caused by biallelic variants in ALDH7A1, PNPO, or PLPBP, a few patients present a similar clinical phenotype but without confirmed molecular diagnoses. We report a child with a 13-year PDE diagnosis and normal intellectual development, whose seizures recurred after pyridoxine withdrawal but resolved with reintroduction, despite unremarkable whole-exome sequencing results. Methods: Following negative results from WES, optical genome mapping (OGM) and whole-genome sequencing (WGS) were performed to highlight any potential structural variants involving known PDE-associated genes. Results: OGM and WGS revealed a recurrent 16p11.2 BP4-5 duplication, inherited from his healthy father, along with a de novo chromothripsis-type unbalanced t(1;18)(p22.3;q12.3), affecting several genes not currently associated with epilepsy (RIT2, PIK3C3, COL24A1, LRRC8D, DIPK1A, and DPYD), with RIT2 being a plausible candidate for the neurological phenotype due to its neuron-specific expression along with a likely reshuffling of topologically associating domains (TADs) involving SYT4, an epilepsy-candidate gene. Discussion: While the molecular data do not pinpoint a single gene or locus as the cause of seizures in this case, a key aspect of our patient’s phenotype is true pyridoxine dependence, rather than just pyridoxine responsiveness. We propose that the genomic complexity associated with the chromothriptic t(1;18) and the 16p11.2 BP4-5 duplication may create a unique metabolic environment in which pyridoxine-dependent pathways are disrupted through unconventional mechanisms. The preservation of cognitive function in our case has been observed in small groups of PDE patients, especially those diagnosed and treated early. This may indicate a distinct phenotypic subgroup that warrants further genetic investigation.

Verified
Journal Article
Open access
PDF file
PFPinella Failla
Pinella Failla
LSLucia Saccuzzo
Lucia Saccuzzo
OGOrnella Galesi
Ornella Galesi
DGDonatella Greco
Donatella Greco
Vincenza BarresiVincenza Barresi
Vincenza Barresi
MFMarco Fichera
Marco Fichera
This study describes two siblings from consanguineous parents who exhibit intellectual disability, microcephaly, photosensitivity, bilateral sensorineural hearing loss, numerous freckles, and other clinical features that suggest a potential disruption of the nucleotide excision repair (NER) pathway. Whole exome sequencing (WES) identified a novel homozygous missense variant in the ERCC4 gene, which was predicted to be pathogenic. However, a subsequent peculiar audiometric finding prompted further investigation, revealing a homozygous deletion in the OTOA gene linked to neurosensorial hearing loss. Both variants were located within a run of homozygosity (ROH) on chromosome 16p13.12-p12.2, implicating a complex genetic basis for the observed phenotype. While this study reports a potentially novel ERCC4 variant, it underscores the importance of comprehensive analysis and deep phenotyping in WES data to improve diagnostic accuracy. Our findings advocate for an expanded approach in WES analysis, ensuring more precise diagnoses and improved genetic counseling, particularly when specialized tests for structural variant analysis are unavailable.

23 June 2025 in Gene
Verified
Journal Article
Open access
EBEugenia Borgione
Eugenia Borgione
OGOrnella Galesi
Ornella Galesi
SPSandro Santa Paola
Sandro Santa Paola
MGMariangela Lo Giudice
Mariangela Lo Giudice
MGMarika Giuliano
Marika Giuliano
CSCarmela Scuderi
Carmela Scuderi
Spastic paraplegia type 20 (SPG20), also known as Troyer syndrome, is a complex form of hereditary spastic paraplegia (HSP), caused by biallelic deleterious variants in the SPART gene. We performed whole-exome sequencing (WES) in a 10-year-old boy with spastic paraparesis, dyskinesia, intellectual disability, speech delay, congenital anomalies, white matter changes, and sensorimotor neuropathy. WES revealed a homozygous nonsense variant in exon 4 of SPART (Gln374Ter), which was found in a heterozygous state in the mother and absent in the father. Analysis of polymorphisms from WES data indicated maternal uniparental disomy (UPD) of chromosome 13, explaining the observed homozygosity. This case underscores the importance of parental segregation studies when homozygous variants are identified, as UPD significantly impacts genetic counseling and recurrence risk. It also highlights the value of bioinformatics tools in WES trio analysis to detect UPD, improving diagnostic precision in clinical settings.